drugset / Trial / NCT00442221
The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to assess the safety of a single-tablet dose of Combo Formulation for the treatment of moderate to severe migraines
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Naproxen | Small molecule | — | — |
| Background | Sumatriptan | Unknown | — | — |